Characterization of the novel HLA-A*31:11:02 allele by next generation sequencing.

Alleles Exons / genetics HLA-A Antigens / genetics High-Throughput Nucleotide Sequencing Histocompatibility Testing Humans
HLA next generation sequencing novel allele

Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
08 2022
Historique:
revised: 29 03 2022
received: 16 02 2022
accepted: 30 03 2022
pubmed: 7 4 2022
medline: 20 7 2022
entrez: 6 4 2022
Statut: ppublish

Résumé

HLA-A*31:11:02 differs from A*31:01:02 by one nucleotide substitution at position 565 in exon 3.

Identifiants

DOI: 10.1111/tan.14622 PMID: 35384347
pubmed: 35384347
doi: 10.1111/tan.14622
doi:

Substances chimiques

HLA-A Antigens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

157-158

Informations de copyright

© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Robinson J, Barker DJ, Georgiu X, Cooper MA, Flicek P, Marsh SGE. IPD-IMGT/HLA database. Nucleic Acids Res. 2020;48:D948-D955.
Madeira F, Park YM, Lee J, et al. The EMBL-EBI search and sequence analysis tools APIsin 2019. Nucleic Acids Res. 2019;47:W636-W641.
Marsh SGE, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens. 2010;75:291-455.

Auteurs

Raffaella Azzarone (R)

Regional Center of Immunohematology and Tissue Typing - S. Salvatore Hospital, L'Aquila, Italy.

Maria Scimitarra (M)

Regional Center of Immunohematology and Tissue Typing - S. Salvatore Hospital, L'Aquila, Italy.

Daniela Fracassi (D)

Regional Center of Immunohematology and Tissue Typing - S. Salvatore Hospital, L'Aquila, Italy.

Simona Scacchi (S)

Regional Center of Immunohematology and Tissue Typing - S. Salvatore Hospital, L'Aquila, Italy.

Franco Papola (F)

Regional Center of Immunohematology and Tissue Typing - S. Salvatore Hospital, L'Aquila, Italy.

Articles similaires

Comprehensive comparative analysis and development of molecular markers for Lasianthus species based on complete chloroplast genome sequences.

Yue Zhang, Meifang Song, Deying Tang et al.
1.00
Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH

questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Composants de génome › Gènes › Allèles › Characterization of the novel HLA-A*31:11:02...
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Composants de génome › Gènes › Composants de gène › Exons › Characterization of the novel HLA-A*31:11:02...
questionsmedicales.fr › Facteurs biologiques › Antigènes › Isoantigènes › Antigènes d'histocompatibilité › Antigènes HLA › Antigènes HLA-A › Characterization of the novel HLA-A*31:11:02...
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Séquençage nucléotidique à haut débit › Characterization of the novel HLA-A*31:11:02...
questionsmedicales.fr › Techniques d'investigation › Techniques immunologiques › Tests immunologiques › Test d'histocompatibilité › Characterization of the novel HLA-A*31:11:02...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Characterization of the novel HLA-A*31:11:02...